Skip to main content
SpringerLink
Log in

Krankheiten des Bewegungsapparates

  • Chapter
Arzneimitteltherapie für ältere Menschen

  • 49 Accesses

Zusammenfassung

Das biologische Altern beginnt ab 30 Jahre; als „Ältere“ werden auch in Abhängigkeit vom Betrachter Menschen der 2. Lebenshälfte, z. T. aber auch die Senioren (arbiträr Alter über 70 Jahre) bezeichnet. Im Zusammenhang mit Therapien mit Medikamenten ist die Grenze insofern fließend, als Abweichungen der Therapie von Jüngeren in unterschiedlichen Altersphasen relevant sein können. Dies soll in diesem Kapitel nach Möglichkeit berücksichtigt werden.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Anderson FH, Francis RM, Peaston RT, Waste11 HJ (1997) Androgen supplementation in eugonadal men with osteoporosis: Effects of six months’ treatment on markers of bone formation and resorption. J Bone Miner Res 12: 472-478

    Article  PubMed  CAS  Google Scholar 

  • Barker DJP (1981) The epidemiology of Paget’s disease. Metab Bone Dis Relat Res 3:231

    Article  PubMed  CAS  Google Scholar 

  • Bauss F (1997) Ibandronate in malignant bone diseases and osteoporosis - preclinical results. Onkologie 20: 204 - 208

    Google Scholar 

  • Black DM, Cummings RS, Karpf DB, Cauley JA, Thompson DE, Nevitt MC, Bauer DC, Genant HK, Haskell WL, Marcus R, Ott SM, Tornern JC, Quandt SA, Reiss TF, Ensrud KE, for the Fracture Intervention Trial Research Group (1996) Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Lancet 348: 1535-1541

    Article  PubMed  CAS  Google Scholar 

  • Candeliere GA, Glorieux FH, Prud homme J, St.-Arnaud R (1995) Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med 332: 1546-1551

    Article  PubMed  CAS  Google Scholar 

  • Cartwright EJ, Gordon MT, Freemont AJ, Anderson DC, Sharpe PT (1993) Paramyxoviruses and Paget’s disease. J Med Virol 40: 133-141

    Article  PubMed  CAS  Google Scholar 

  • Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B, Arnaud 5, Delmas PD, Meunier PJ (1992) Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 327: 1637-1642

    Article  PubMed  CAS  Google Scholar 

  • Chapuy MC, Chapuy P, Thomas JL, Hazard MC, Meunier PJ (1996) Biochemical effects of calcium and vitamin D supplementation in elderly, institutionalized, vitamin D-deficient patients. Rev Rhm 63: 135-140

    CAS  Google Scholar 

  • Civitelli R, Connelli S, Zacchei F, Bigazzi S, Vattimo A, Avioli LV, Gennari C (1988) Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. J Clin Invest 82: 1268-1274

    Article  PubMed  CAS  Google Scholar 

  • Collins MR, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Marx SJ (1998) Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimietic agent. J Clin Endocrinol Metab 83: 1083-1088

    Article  PubMed  CAS  Google Scholar 

  • Consensus development conference statement (1991) J Bone Miner Res 6 [Suppl 2]:9-13

    Google Scholar 

  • Cundy T, McAnulty K, Wattie DW, Gamble G, Rutland M, lbbertson HK (1997) Evidence for secular change in Paget’s disease. Bone 20: 69C71

    Article  PubMed  CAS  Google Scholar 

  • Delling G (1975) Endokrine Osteopathien. Fischer, Stuttgart, S 52

    Google Scholar 

  • Draper MW, Flowers DE, Huster WJ, Neild JA (1993) Effects of raloxifene (LY 139481 Hcl) on biochemical markers of bone and lipid metabolism in healthy postmenopausal women. In: Christiansen C, Riis B (eds) Proceedings of the 4th International Symposium on Osteoporosis and Consensus Development Conference Hong Kong. Handelstrykkeriet Aalborg ApS, pp 119-121

    Google Scholar 

  • Francis RM, Boyle IT, Moniz C, Sutcliffe AM, Davis BS (1994) A comparison of the effects of alfacalcidol treatment and vitamin D supplementation on calcioum absorption in elderly women with osteoprosis. In: Norman AW, Bouillon R, Thomasset M (eds) Vitamin D. A pluripotent steroid hormone: Structural studies, molecular endocrinology and clinical applications. Proceedings of the Ninth Workshop on Vitamin D, Orlando, Florida, pp 850-851

    Google Scholar 

  • Erdtsieck RJ, Pols HAP, Van Kuijk C, Birkenhäger-Frenkel DH, Zeelenberg J, Kooy PPM, Mulder P, Birkenhäger JC (1994) Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate. J Bone Miner Res 9: 277-283

    Article  PubMed  CAS  Google Scholar 

  • Grauer A, Heichel S, Knaus J, Ziegler R (1996) Long-term effects of ibandronate treatment in Paget’s disease of bone. J Bone Miner Res [Suppl 11: 498

    Google Scholar 

  • Hackenthal E (1988) Therapie mit Analgetika and nicht-steroidalen Antirheumatika. In: Platt D (Hrsg) Pharmakotherapie and Alter. Springer, Berlin Heidelberg New York Tokyo, S 155-190

    Google Scholar 

  • Harris ST, Watts NB, Jackson RD, Genant HK, Wasnich RD, Ross P, Miller PD, Licata AA, Chesnutt III CH (1993) Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy. Am J Med 95: 557-567

    Article  PubMed  CAS  Google Scholar 

  • Harvey HA, Lopton A, Demers LM, Seaman J(1996) Pamidronate therapy of bone metastases in breast and prostate cancer - the U.S. experience. In: Possinger K, Ziegler R (eds) Bisphosphonate-improved treatment of osteolysis in malignant and non-malignant indications. Ciba-Geigy Verlag, Wehr, pp 21-30

    Google Scholar 

  • Limouzin-Lamathc M-A (1988) A review of patient’s attitudes towards osteoporosis and its treatment (Italy, France and USA). In: Christiansen C (ed) New horizons in osteoporosis. Parthenon Publ. Group, Casterton Hall, Park Ridge, pp 43-49

    Google Scholar 

  • Lippert TH, Muck OA (1997) Brustkrebsrisiko bei postmenopausaler Ostrogentherapie. Das Dilemma der Risikobeurteilung. Dtsch med Wochenschr 122: 908-911

    Google Scholar 

  • Morrison N, Qi JC, Tokita A, Keily P, Criofts L, Ngyuen TV, Sambrook PN, Eisman JA (1994) Prediction of bone density by vitamin receptor allele. Nature 367: 284-287

    Article  PubMed  CAS  Google Scholar 

  • Niederstadt, C, Steinhoff J (1997) Die Nieren im Alter. Z Geront Geriatrie 30:200-207

    CAS  Google Scholar 

  • NIH consensus statement (1994) Optimal calcium intake, vol 12, p 7

    Google Scholar 

  • Pak CYC, Zerwekh JE, Antich PP, Beil NH, Singer FR (1996) Slow-release sodium fluoride in osteoporosis. J Bone Miner Res 11: 561-564

    Article  PubMed  CAS  Google Scholar 

  • Pak CYC, Sakhaee K, Rubin CD, Zerwekh JE (1997) Sustained-release sodium fluoride in the management of established postmenopausal osteoporosis. Am J Med Sci 313: 23-32

    Article  PubMed  CAS  Google Scholar 

  • Paterson AHG, Powies TJ, Kanis JA, McCloskey E, Hanson J, Ashley S (1993) Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer. J Clin Oncol 11: 59-65

    PubMed  CAS  Google Scholar 

  • Peacock M (1995) Vitamin D receptor gene alleles and osteoporosis: a contrasting view. J Bone Miner Res 10: 1294-1297

    Article  PubMed  CAS  Google Scholar 

  • Posen S (1992) Asymptomatic primary hyperparathyroidism: the case for conservative management. Aust NZ J Med 22: 161-163

    Article  CAS  Google Scholar 

  • Quigley MET, Martin PL, Bumier AM, Brooks P (1987) Estrogen therapy arrests bone loss in elderly women. Am J Obstet Gynecol 156: 1516-1523

    PubMed  CAS  Google Scholar 

  • Ravn P, Clemmesen B, Riis BJ, Christiansen C (1996) The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebocontrolled dose-finding study. Bone 19: 527-533

    Article  PubMed  CAS  Google Scholar 

  • Ray WA, Downey W, Griffin MR, Melton III LJ (1989) Long-term use of thiazide diuretics and risk of hip fracture. Lancet 1: 687-690

    Article  PubMed  CAS  Google Scholar 

  • Riggs BL, Hodgson SF, O’Fallon WM, Chao EYS, Wahner HW, Muhs JM, Cedel SL, Melton LJ III (1990). Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med 322: 802-809

    Article  PubMed  CAS  Google Scholar 

  • Riggs BL, O’Falion WM, Lane A, Hodgson SF, Wahner HW, Muhs J, Chao E, Melton LJ III (1994) Clinical trial of fluoride therapy in postmenopausal osteoporotic women: extended observations and additional analysis. J Bone Miner Res 9: 265-275

    Article  PubMed  CAS  Google Scholar 

  • Rowe PSN, Ong ACM, Cockerill FJ, Goulding JN, Hewison M (1996) Candidate 56 and 58 kDa protein(s) responsible for mediating the renal defects in oncogenic hypophosphatemic osteomalacia. Bone 18: 159-169

    Article  PubMed  CAS  Google Scholar 

  • Schmorl G (1932) fiber Ostitis deformans Paget. Virchow‘s Arch 283:694

    Google Scholar 

  • Schwabe U (1997) Rheumatische Krankheiten. In: Scholz H, Schwabe U (Hrsg) Taschen- buch der Arzneibehandlung. Fischer Verlag, Lübeck Stuttgart Jena Ulm, S 261-272

    Google Scholar 

  • Selby SL, Peacock M (1986) Ethinyl estradiol and norethindrone in the treatment of pri- mary hyperparathyroidism in postmenopausal women. N Engl J Med 314: 1481-1485

    Article  PubMed  CAS  Google Scholar 

  • Strasburger CJ, Schopohl J, Kann P, Oertel H für die Arbeitsgemeinschaft Hypophyse und Hypophysentumore der Deutschen Gesellschaft für Endokrinologie (1987) Diagnostische Kriterien für die Indikation zur Wachstumshormon-Substitution bei Erwachsenen. Dtsch med Wochenschr 122: 861-863

    Article  Google Scholar 

  • Tilyard MW, Spears GF, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326: 357-362

    Article  PubMed  CAS  Google Scholar 

  • Toogood AA, Adams JE, O’Neill PA, Shalet SM (1997) Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J Clin Endocrin Metab 82: 1462-1466

    Article  CAS  Google Scholar 

  • Wasnich R, Davis J, Ross P, Vogel J (1990) Effect of thiazide on rates of bone mineral loss: a longitudinal study. BMJ 301: 1303-1305

    Article  PubMed  CAS  Google Scholar 

  • Weinstein RS (1997) Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density. J Bone Miner Res 12: 1314-1315

    Article  PubMed  CAS  Google Scholar 

  • Wüster C, Slenczka E, Ziegler R (1991) Erhöhte Prävalenz von Osteoporose und Arteriosklerose bei konventionell substituierter Hypophysenvorderlappeninsuffizienz: Bedarf einer zusätzlichen Wachstumshormonsubstitution? Klin Wochenschr 69: 769-773

    Article  PubMed  Google Scholar 

  • Ziegler R, Holz G, Rotzler B, Minne H (1985) Paget‘s disease of bone in West Germany. Prevalence and distribution. Clin Orthop 194: 199-204

    PubMed  Google Scholar 

  • Ziegler R, Scheidt-Nave C, Scharla S (1995) Pathophysiology of osteoporosis: Unresolved problems and new insights. J Nutr 125: 2033-2037

    Google Scholar 

Download references

Authors
  1. R. Ziegler
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69-73, 14195, Berlin, Deutschland

    Franz von Bruchhausen

  2. Institut für Pharmakologie und Toxikologie, Universität Mannheim, Maybachstraße 14-16, 68169, Mannheim, Deutschland

    Björn Lemmer

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Ziegler, R. (2000). Krankheiten des Bewegungsapparates. In: von Bruchhausen, F., Lemmer, B. (eds) Arzneimitteltherapie für ältere Menschen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59590-5_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59590-5_9

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-64851-2

  • Online ISBN: 978-3-642-59590-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation